Senior biotech head announces departure from Bayer

In a  post on LinkedIn, Bayer (BAYN: DE) senior vice president and biotech head Jens Vogel has announced his intention to step down.

Mr Vogel joined the company at the start of the coronavirus pandemic, in March 2020, and led the firm’s integrated global biotech network, improving operations and product supply as well as tech development across facilities in Europe and the USA.

Thanks to improvements in the efficiency of Chemistry, Manufacturing, and Controls (CMC) development, Mr Vogel said Bayer was now “among the top four pharma / biotech companies in biologics CMC efficiency, as per McKinsey’s benchmarking.”